Skip to main content
. 2010 Sep-Oct;30(5):350–357. doi: 10.4103/0256-4947.67078

Table 2.

Characteristics of women enrolled in the screening program (n=1215).

n (%)
Family history cancer
 Positive family history 142 (11.7)
 Negative family history 1064(87.6)
 Unknown or missing 9 (0.7)
Estrogen use
 Yes 874 (71.9)
 No 202 (16.)
 Unknown or missing 139 (11.4)
Early menarche
 Yes 145 (11.9)
 No 1042 (85.8)
 Unknown or missing 28 (2.3)
Menopausal status
 Yes 294 (24.2)
 No 883 (72.7)
 Unknown or missing 38 (3.1)
Late parity
 Yes 113 (9.3)
 No 1073 (88.3)
 Unknown or missing 29 (2.4)
Nulliparity
 Yes 53 (4.4)
 No 1145 (94.2)
 Unknown or missing 17 (1.4)
Previous breast surgery or biopsy
 Yes 68 (5.6)
 No 1142 (93.9)
 Unknown or missing 5 (0.4)
Symptoms
 Symptomatica 475 (39.1)
 Breast mass 183 (15.1)
 Nipple inversion or retraction 22 (1.8)
 Breast pain 379 (31.2)
 Nipple discharge 16 (1.3)
 Asymptomatic 607 (50.0)
 Unknown or missing 133 (10.9)
a

Raw numbers of the individual symptoms do not add up to the total due to overlap (one patient may have more than one symptom). Percentages of the individual symptoms are calculated from the total sample (n=1215).